NIH-funded research Career grant

Understanding liver disease related to nuclear lamins

Official title: Nuclear lamins and the hepatocyte nuclear envelope in nonalcoholic fatty liver disease

Funded at University of Michigan at Ann Arbor · NIH-10771130 · Data updated 2026-11-12

This study is looking at how certain proteins in our cells might affect nonalcoholic fatty liver disease (NAFLD) by using zebrafish to better understand the disease and find new ways to treat it.

More Fatty Liver research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startMarch 3, 2020
Project endJanuary 31, 2026
Funding year2024
Award (this year)$167,400
NIH project number5K08DK120948-05
Project IDNIH-10771130 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with nonalcoholic fatty liver disease, particularly those with genetic mutations affecting nuclear lamina components.

Less likely to help

Patients with liver diseases unrelated to nuclear lamins or those without NAFLD may not benefit from this research.

What this research studies

This research investigates the role of nuclear lamins in nonalcoholic fatty liver disease (NAFLD) using advanced techniques in genomics and bioinformatics. The principal investigator, Dr. Graham Brady, aims to uncover the mechanisms behind NAFLD by studying a unique model organism, zebrafish, which allows for detailed observation of liver function and disease progression. The project combines clinical expertise in hepatology with innovative research methodologies to enhance our understanding of this prevalent liver condition. By identifying genetic factors and cellular processes involved in NAFLD, the research seeks to pave the way for new therapeutic strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for patients suffering from nonalcoholic fatty liver disease.

How similar studies have gone: Previous research has shown promise in understanding liver diseases through genetic and cellular studies, indicating that this approach could yield valuable insights.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Brady, Graham F. — University of Michigan at Ann Arbor
  • Study coordinator: Brady, Graham F.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.